Preliminary CT Perfusion Study of Functioning Pancreatic Endocrine Tumor by 16 MSCT
Liu Yu,Lin Xiao-zhu,Xu Xue-qin
DOI: https://doi.org/10.3969/j.issn.1006-5741.2008.01.010
2008-01-01
Abstract:Purpose:To evaluate the differentia of the characteristics of MSCT perfusion between functioning pancreatic endocrine tumor and tumor-free pancreatic parenchyma.Materials and Methods:12 patients(5 male,7 female,age range 25-69y,mean age 43.4y)who suffering from functioning pancreatic endocrine tumor underwent CT perfusion scan by GE LightSpeed 16 MSCT.Dynamic enhancement scanning was carried out for the same chosen sections of pancreatic lesions after contrast agent bolus injection with scan delay time 5-7s,injection rate 3.5ml/s and total injection volume 50ml.Then the raw images were delivered to GE AW4.2 Workstation and the time density curves(TDC),blood flow(BF),blood volume(BV),mean transit time(MTT),vascular permeability-surface(PS) and time to peak(TTP) of pancreatic lesions and tumor-free pancreas were calculated and analyzed with the dedicated CT-perfusion 3 software.Results:The mean BF,BV,MTT and PS of the functioning pancreatic endocrine tumor were(287.73±140.97)ml/(min·100g),(18.48±5.17)ml/100g,(5.96±3.07)s,(17.37±11.10)ml/(min·100g),respectively.The mean BF,BV,MTT and PS of normal pancreas tissue were(162.4792.44)ml/(min·100g),(11.77±3.54)ml/100g,(7.13±3.02)s,(17.54±12.88)ml/(min·100g),respectively.Functioning pancreatic endocrine tumor had higher BF and BV(P=0.02,t=3.257;P=0.000,t=4.71)but no significant difference in MTT and PS(P=0.230,t=-1.218;P=0.965,t=-0.044) compared with those of normal pancreas.The mean time to peak of functioning pancreatic endocrine tumor and normal pancreatic tissue was(27.17±4.98)s,(27.96±4.09)s respectively and there was no significant difference between them(P=0.591,t=-0.542) Conclusion:The CT-perfusion characteristics were proved to be different between functioning pancreatic endocrine tumor and normal pancreatic tissue by some perfusion parameters which were considered to be helpful for the diagnosis of the functioning pancreatic endocrine tumor.